Health Care
LLY · Eli Lilly
$1,183.46 Close · 2026-09-25
Close50-day avg200-day avg
Short-term view (1–4 weeks)
BuyRank #19 of 8572
+ Strengths
- + RSI in the healthy 50–70 momentum zone
- + MACD turning up (bullish crossover)
- + buyers in control this week
− Risks
- − large daily swings — wider stops needed
Entry, stop and target levels plus the full factor breakdown are free with an account.Join free
Long-term view (6–24 months)
BuyRank #9 of 8567
+ Strengths
- + strong revenue growth
- + persistent 12-month uptrend
- + excellent return per unit of risk
− Risks
- − expensive valuation vs peers
- − high volatility
Entry, stop and target levels plus the full factor breakdown are free with an account.Join free
Fundamentals
- Market cap
- $1.11T
- P/E (TTM)
- 41.7
- Return on equity
- 92.6%
- Revenue growth (YoY)
- +49.6%
- Net margin
- 33.5%
- Debt / equity
- 1.62
- Dividend yield
- 0.52%
- Beta
- 0.43
- 52-week high
- $1,292.65
- 52-week low
- $712.05
Latest news
Company news is included with a free account.
Model output for education and research — not financial advice or a personal recommendation. Always do your own research and manage your risk.